Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/1/24 17:54 | 9/27/24 | WVE | Health | Drug | Pharmaceutical Preparations | Gsk Plc | X0 | T | P | 22,335 | 8.00 | 0 | 2,792 | 20 | 16,776 | I | |||||||||||||||
1/30/24 16:39 | 12/7/23 | WVE | Health | Drug | Pharmaceutical Preparations | Gsk Plc | X0 | T | P | 16,500 | 5.00 | 0 | 3,300 | 31 | 13,984 | I | |||||||||||||||
1/17/24 19:06 | 12/11/23 | WVE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | P.a | 5,000 | 5.00 | 0 | 1,000 | 6 | 18,202 | I | |||||||||||||||
12/13/23 16:33 | 12/11/23 | WVE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | P | 5,000 | 5.00 | 0 | 1,000 | 5 | 19,202 | I | |||||||||||||||
6/21/22 16:33 | 6/16/22 | WVE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | P.d | 20,382 | 2.15 | 0 | 9,480 | 123 | 17,202 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |